drugset / Trial / NCT03514615
A Trial to Assess the Safety and Efficacy of Topical Salbutamol in Healthy Volunteers.
Phase 1
Completed
45 enrolled
University Hospitals, Leicester
Medical Research Council · collabUniversity of Leicester · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This will be a single centre, double-blind, placebo (vehicle) controlled, randomised, dose escalation trial. Three concentrations of topical salbutamol gel will be compared, in a group-wise fashion, with a placebo administration at one incision site on each arm of the trial subjects. Each participant will be allocated to only one dosing group. The treatments will be paired anatomically so that for each pair of sites, one closed incision site will receive the active substance, while the other will receive placebo.
Timeline
- Start
- 2018-01-10
- Primary completion
- 2018-07-20
- Completion
- 2019-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Salbutamol | Unknown | — | Topical |
Indications
No indication recorded.